Sally Edgington
Chief Executive officer, AXREM
Transforming healthcare starts with modern diagnostics, smarter technology and bold national ambition.
The pressure on NHS diagnostic services has become a defining challenge of our time. Imaging, radiotherapy and digital health are no longer supporting functions, but the backbone of modern care pathways, enablers of early diagnosis and catalysts for systemwide efficiency. To transform UK healthcare, diagnostics must be at the centre of national strategy.
Governance and investment key to unlocking technological innovations
As AXREM’s CEO, representing the UK’s leading medical imaging, radiotherapy and digital health manufacturers and suppliers, I see every day how innovation is reshaping what’s possible. The technologies exist, and the clinical need is clear. What’s required is the policy ambition and investment to unlock their full potential.
Diagnostic imaging demand continues to outstrip workforce capacity and ageing equipment limits productivity. Modern scanners, AI‑enabled workflows and integrated digital platforms can dramatically improve throughput, accuracy and patient experience, but adoption remains uneven. National replacement programmes, long‑term capital planning and clear digital standards are essential if we want to build a future‑ready diagnostic service.
To transform UK healthcare,
diagnostics must be at the centre of national strategy
Innovation opportunities across radiology and radiotherapy
AI is already delivering meaningful impact across radiology and radiotherapy. From triage tools to advanced image interpretation, AI can support clinicians, reduce backlogs and enhance safety. But without consistent governance, procurement pathways and implementation support, the NHS risks missing the opportunity to scale these benefits. AXREM’s AI Manifesto sets out a practical, clinician‑led approach to safe and effective adoption, one that industry stands ready to deliver.
Radiotherapy, too, is an area where innovation can transform outcomes. Modern treatment planning systems, imaging‑guided therapies and digital QA tools can improve precision and reduce variation. Investment in radiotherapy technology is an investment in survival.
Digital health underpins all of this. Interoperability, data quality and national standards are the foundations of a modern diagnostic ecosystem. Without them, innovation cannot scale.
The NHS has world‑class clinicians and a vibrant industry ready to partner. By prioritising diagnostics imaging, AI, radiotherapy and digital health, we can build a faster, safer and more resilient system. The opportunity is here; I hope this Government seizes it.
